Delivering market success for concept to patient
Posted: 24 October 2024 | | No comments yet
Now more than ever, contract manufacturing partners must deliver continuous innovation and flexibility to accommodate the delivery of a wide range of drugs throughout each product’s lifecycle. These partners, either by utilizing existing technology platforms or developing a proprietary drug delivery system, need to support pharmaceutical companies with products and
processes that facilitate the development of market-ready therapies that are safe, effective and easy to administer.
Related content from this organisation
- Whitepaper: Risk-Based Approach to Development – Injectable Combination Product
- Delivering market success for concept to patient
- A data-driven approach to Container Closure Integrity
- CPHI Milan 2024: everything you need to know
- How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging
Related topics
Analytical techniques, Biologics, Biopharmaceuticals, Drug Delivery Systems, Medical Devices, Packaging, QA/QC, Research & Development (R&D), Sustainability